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ABSTRACT Tritrpticin is a member of the cathelicidin family of antimicrobial peptides. Starting from its native sequence
(VRRFPWWWPFLRR), eight synthetic peptide analogs were studied to investigate the roles of speciﬁc residues in its biological
and structural properties. This included amidation of the C-terminus paired with substitutions of its cationic and Phe residues, as
well as the Pro residues that are important for its two-turn micelle-bound structure. These analogs were determined to have a
signiﬁcant antimicrobial potency. In contrast, two other peptide analogs, those with the three Trp residues substituted with either
Phe or Tyr residues are not highly membrane perturbing, as determined by leakage and ﬂip-ﬂop assays using ﬂuorescence spec-
troscopy. Nevertheless the Phe analog has a high activity; this suggests an intracellular mechanism for antimicrobial activity that
maybepart of the overallmechanismof action of native tritrpticin as a complement tomembraneperturbation. NMRexperiments of
these twoTrp-substituted peptides showed thepresenceofmultiple conformers. The structures of the six remainingTrp-containing
analogs bound to dodecylphosphocholine micelles showed major, well-deﬁned conformations. These peptides are membrane
disruptive and show awide range in hemolytic activity. Their micelle-bound structures either retain the typical turn-turn structure of
native tritrpticin or have an extended a-helix. This work demonstrates that closely related antimicrobial peptides can often have
remarkably altered properties with complex inﬂuences on their biological activities.
INTRODUCTION
In recent years, there has been an increasing interest in un-
derstanding the antimicrobial mechanism of the tryptophan-
rich (Trp-rich) class of antimicrobial peptides (1). The best
studied of the Trp-rich class of peptides is indolicidin (2) for
which there have been numerous structure-function studies
performed (3–8). The primary sequence of tritrpticin is very
similar to that of indolicidin; both have ﬁve aromatic resi-
dues, and multiple Pro and basic residues (9). Tritrpticin has
an extra positive charge compared to indolicidin with the
four positively charged residues of tritrpticin equally local-
ized to the N- and C-termini.
After the initial description of tritrpticin and the NMR
structure determination in sodium dodecyl sulfate micelles
(SDS) (9,10), several structure-function analyses of tritrpticin
have been performed to better understand the mechanism
of action of the peptide and improve its efﬁcacy as an anti-
microbial agent (11–13). For example, because the sequence
of tritrpticin is very nearly palindromic, Nagpal et al. (11)
designed a variant of tritrpticin in which Val-1 and Leu-11
were removed to create a symmetric peptide, which was signi-
ﬁcantly more active than the parent molecule. In fact, Val-1
is probably not present nor essential in the native peptide,
because this residue is likely removed during the proteolytic
cleavage of the parent cathelicidin pro-domain (14). Indeed,
removal of the terminal Val does not signiﬁcantly alter the
activity of the peptide (11). This is also in agreement with the
fact that there are no observable interactions between Val-1
and the rest of the micelle-bound peptide (10).
In this work, we have studied several analogs of tritrpticin
in which changes were introduced to perturb its membrane
binding properties and/or its membrane-bound structure.
A ﬁrst change that we introduced is the amidation of the
carboxy-terminal end of the tritrpticin. This substitution is
found naturally in indolicidin and removes the sole negative
charge of these peptides. This substitution is expected to give
rise to a higher antimicrobial activity because it would
reduce the electrostatic repulsion between the C-terminus of
the peptides and the phosphodiester group of the phospho-
lipids. A second change involves altering the aromatic resi-
dues. As is commonly observed for antimicrobial peptides
(15), replacement of the three Trp residues of tritrpticin by
Ala abolishes the antimicrobial activity (12). We therefore
elected to replace the three Trp residues with Phe or Tyr.
Replacement of Trp with Tyr is seemingly attractive because
its side chain, like that of Trp, prefers to locate itself in the
membrane interface, whereas the side chain of Phe typically
penetrates deeper into the central portion of the membrane
(16,17). To also determine the effect of the two Phe residues
in the sequence of tritrpticin on the activity, we decided to
substitute these by Tyr residues, which would be expected
to inﬂuence the positioning of the peptide in the membrane.
A third change could focus on the cationic residues of
tritrpticin. The four cationic residues at the terminal ends of
tritrpticin are important for its antibacterial activity because
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the removal of even one Arg decreases the activity (11). How-
ever, it is not essential that the cationic residues be Arg, as
their replacement with Lys is apparently not deleterious to the
activity of either tritrpticin or its symmetric variant (11,13).
The NMR structure of indolicidin in dodecylphosphocho-
line micelles (DPC) was determined to be an extended turn-
like structure (18). This is in contrast to the NMR structure of
tritrpticin, which formed a compact two-turn amphipathic
structure in SDS micelles (10). The two Pro residues of
tritrpticin helped form the two turns in this structure, and it
would therefore be of interest to replace these two residues
with Ala as well. The cis-trans proline isomerization ob-
served for tritrpticin in aqueous solution was signiﬁcantly
decreased upon insertion into detergent micelles, inducing
the formation of a single major conformer. This X-Pro
cis-trans isomerization has also been observed for indolici-
din, although indolicidin does not form a single conformer in
detergent as readily as tritrpticin (D. J. Schibli and H. J.
Vogel, unpublished data; (18)). The substitution of Pro, a
helix-breaking residue, to Ala, a helix-promoting residue,
results in the formation of a continuous a-helical structure
for indolicidin in DPCmicelles (7) as well as for hCT (9–32),
a human calcitonin-derived cell-penetrating peptide (19).
Recently, the NMR structures of a number of other short
Trp-rich peptides have also been determined; the vast major-
ity form amphipathic structures in detergent micelles, with
the Trp residues forming the hydrophobic core of an amphi-
pathic structure (10,20–24).
We have previously investigated the interactions of
tritrpticin with large unilamellar vesicles and have observed
that both tritrpticin and indolicidin preferentially insert into
the membrane/water interface of phospholipid vesicles with
negatively charged headgroups (23). In addition, as men-
tioned above, the solution NMR structure of tritrpticin has
also been determined in SDS micelles (10). In this work, we
compare a group of eight amidated analogs of tritrpticin
(Table 1) in which sets of amino acids have been system-
atically examined to determine their effects on antimicrobial
activity, membrane perturbation properties, and structures in
detergent micelles.
MATERIALS AND METHODS
Materials and peptide synthesis
All peptides used in this study were synthesized using standard ﬂuoromethoxy
carbonyl (fmoc) chemistry. Tritrpticin, indolicidin, and Tritrp6 and 7 were
synthesized at the Peptide Synthesis Facility at Queens University
(Kingston, Ontario, Canada). Tritrp1–5 were synthesized at the University
of Victoria Protein Chemistry Centre (Victoria, British Columbia, Canada)
on an Applied Biosystems (Foster State, CA) model 430A peptide synthe-
sizer. Tritrp8 was purchased from AnaSpec (San Jose, CA). All peptides were
puriﬁed to.95% purity using reverse-phase high-performance liquid chroma-
tography. All lipids, including the ﬂuorophore labeled 1-oleoyl-2-[6-[(7-
nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sn-glycero-3-phosphocholine
lipid (C6-NBD-PC), were purchased from Avanti Polar Lipids (Alabaster,
Ala). Calcein and a-chymotrypsin were purchased from Sigma (St. Louis,
MO). All other chemicals were purchased from standard suppliers.
Antimicrobial and hemolytic assays
The antimicrobial activities of the peptides used in this study were assayed
using the broth microdilution method by determining both the minimal in-
hibitory concentration (MIC) and minimal bactericidal concentration (MBC)
as described previously (25). Brieﬂy, Escherichia coli and Staphylococcus
aureus strains were grown to the exponential growth phase in 2% Bacto-
Peptone media and diluted to 2 3 106 cfu/mL in the wells of a 96-well
polystyrene plate. The peptides were diluted between 100 and 1 mg/mL and
the cultures were incubated overnight at 37C. The change in turbidity of the
bacteria cultures was monitored at 540 nm with a Microwell System Reader
510 spectrophotometer (Organon Teknika, Boxtel, The Netherlands). The
MBC was determined by removing a 10-mL aliquot from the overnight
culture and plating on Paper Disk Method antibiotic sensitivity medium II
(AB Biodisk, Solna, Sweden) and incubating for a second night at 37C.
The hemolytic assay was performed using red blood cells from hepa-
rinized human blood as previously described (25). Brieﬂy, freshly collected
human blood was centrifuged at 1500 rpm for 10 min at 4C and washed
with phosphate buffered saline, pH 7.3. Red blood cells were diluted to 1%
and incubated with various peptide dilutions for 1 h at 37C. Samples were
subsequently centrifuged at 4000 rpm for 5 min before the absorbance of the
supernatant was measured at 540 nm. A zero hemolysis blank and a mea-
surement of 100% hemolysis (cells lysed by 1% Triton X-100) were also
determined. The concentration of peptide required for 50% hemolysis
(EC50) was determined from dose-response curves. The antimicrobial and
hemolytic assays were both performed at the University Hospital of Trømso
(Trømso, Norway).
Calcein leakage
A standard calcein leakage assay (26) was performed to determine the effects
of various peptides on the permeability of synthetic large unilamellar vesi-
cles (LUVs). LUVs were prepared using the extrusion method as previously
described (20). LUVs were made of lipid mixtures of egg-yolk phosphatidyl
choline (ePC), egg-yolk phosphatidyl ethanolamine (ePE), and egg-yolk
phosphatidyl glycerol (ePG) in 1:1 ratios for both ePC:ePG and ePE:ePG.
Additionally, ePC LUVs containing cholesterol were made with a compo-
sition of ePC:cholesterol in a 2.5:1 ratio. Lipid ﬁlms were formed by mixing
phospholipids dissolved in chloroform followed by evaporation of the chlo-
roform under a stream of nitrogen gas. The lipid ﬁlms were solubilized in
leakage buffer (10 mM Tris, 150 mM NaCl, 1 mM EDTA, pH 7.4) and
70 mM calcein. The lipid suspensions were further processed with ﬁve
cycles of freezing and thawing, followed by a minimum of 11 passes through
two stacked 0.1-mm polycarbonate ﬁlters (Nucleopore Filtration Products,
Pleasanton, CA) using a Mini-Extruder (Avanti Polar Lipids) at room tem-
perature (27,28). After extrusion, free calcein was removed from the LUVs
with encapsulated calcein by gel ﬁltration on an 18-cm Sephadex G-50
TABLE 1 Sequences of the tritrpticin analogs
Peptide Variant Sequence
Tritrpticin VRRFPWWWPFLRR
Tritrp1 NH2 VRRFPWWWPFLRR-NH2
Tritrp2 R/K VKKFPWWWPFLKK-NH2
Tritrp3 P/A VRRFAWWWAFLRR-NH2
Tritrp4 W/Y VRRFPYYYPFLRR-NH2
Tritrp5 F/Y VRRYPWWWPYLRR-NH2
Tritrp6 W/F VRRFPFFFPFLRR-NH2
Tritrp7 P1/A1 VRRFAWWWPFLRR-NH2
Tritrp8 P2/A2 VRRFPWWWAFLRR-NH2
Indolicidin ILPWKWPWWPWRR-NH2
Sequence changes relative to the parent tritrpticin peptide are denoted by
bold text.
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column equilibrated with leakage buffer. Fractions containing LUVs were
determined by light scattering at 400 nm. The phospholipid concentration
was determined by assaying lipid phosphorus by the method of Ames (29).
Leakage experiments were performed on a Varian Cary Eclipse ﬂuori-
meter with excitation and emission wavelengths of 490 nm and 520 nm,
excitation and emission slit widths of 5 nm, and a PMT detector voltage
of 400 V. Measurements were carried out in a 2-mL sample volume with
mixing and a sample temperature of 37C using a Peltier temperature control
device. Calcein-encapsulated LUVs were diluted in leakage buffer to a ﬁnal
phospholipid concentration of 10mM. For higher lipid concentrations, LUVs
prepared in leakage buffer lacking calcein were added. To induce calcein
leakage, peptide was added to a ﬁnal concentration of 1 mM. The degree of
calcein leakage was assessed at peptide to lipid (P/L) ratios of 1:10, 1:20,
1:30, 1:50, 1:100, and 1:200. Using the Kinetics program in the Cary Eclipse
software package, the baseline ﬂuorescence was monitored for a minimum
of 1–2 min (Fo). After the addition of peptide the increase in ﬂuorescence
due to the dilution of the calcein dye (F) was monitored for 10 min or until
the ﬂuorescence no longer increased. The total calcein ﬂuorescence (FT) was
determined by the addition of 20 mL of 10% Triton X-100, with the ﬂuo-
rescence monitored for a minimum of 1 min or until the ﬂuorescence read-
ings had stabilized. All values were averaged over 1–10 s and the assays
were performed in triplicate. The percent leakage was calculated as follows:
%Leakage ¼ ððF FoÞ=ðFT  FoÞÞ3100:
Lipid ﬂip-ﬂop
Asymmetrically labeled NBD vesicles for lipid ﬂip-ﬂop experiments (23)
were made by the extrusion method with an Avanti miniextruder (Avanti
Polar Lipids). Vesicles were made using a lipid composition of 1:1:0.005
ePC:ePG:C6-NBD-PC and solubilized in leakage buffer. After extrusion, the
LUVs are symmetrically labeled with the C6-NBD-PC ﬂuorophore in both
leaﬂets of the bilayer. To produce asymmetrically labeled LUVs, the outer
leaﬂet NBD ﬂuorophores were chemically quenched by incubating the
LUVs with 60 mM dithionite (60 mL of 1 M dithionite, 1 M Tris added to
1 mL of LUVs) for 20 min at 30C. Immediately after this, the dithionite was
removed by gel ﬁltration on a Sephadex G-50 column, and fractions con-
taining the asymmetrically labeled LUVs were monitored by light scattering
at 400 nm and pooled. The asymmetric NBD labeled LUVs were diluted to
10 mM in 19 mL of leakage buffer and allowed to equilibrate for a minimum
of 20 min at 37C. Before the addition of peptide, a zero time point was
obtained to determine background lipid ﬂip-ﬂop. To induce lipid ﬂip-ﬂop,
peptides were added to a ﬁnal concentration of 0.2 mM, giving a peptide/
lipid ratio of 1:50. Samples were removed at time points of 30, 60, 120, 300,
and 600 s. To stop the ﬂip-ﬂop reaction, samples were immediately mixed
with 30 mL of 25 mg/mL a-chymotrypsin and incubated at 30C for a
minimum of 30 min. The NBD ﬂuorescence was monitored on a Varian
Cary Eclipse ﬂuorimeter with excitation and emission wavelengths of 460
nm and 537 nm, excitation and emission slit widths of 10 nm, a PMT
detector voltage of 600 V, and Savitzky-Golay averaging with a 5-nm ﬁlter.
Measurements were carried out in a 3-mL sample volume and a sample
block temperature of 30C with mixing. Using the Kinetics software in the
Cary Eclipse software package, ﬂuorescence was monitored for a minimum
of 2 min or until the NBD ﬂuorescence had equilibrated. The degree of
peptide-induced ﬂip-ﬂop of the NBD labeled PC lipid, was determined by
the addition of 30 mL of 1 M dithionite, 1 M Tris. The decrease in ﬂuore-
scence was monitored over time until the ﬂuorescence had equilibrated
(5–20 min). To determine the background ﬂuorescence, the LUVs were
disrupted by the addition of 15 mL of 20% Triton X-100, and the remaining
NBD-labeled lipids were quenched by dithionite. The background ﬂuores-
cence was monitored for ;2 min or until the baseline had stabilized. The
percent ﬂip-ﬂop was calculated as follows:
%flip-flop ¼ ð100 ððF FbkgÞ=ðFo  FbkgÞÞ3100Þ;
where F is the average ﬂuorescence after complete quenching of any ﬂipped
lipids (usually measured at 20 min after the addition of dithionite), Fbkg is
the average ﬂuorescence after the addition of Triton X-100, and Fo is the
average ﬂuorescence before the addition of peptide. To remove variability,
all ﬂuorescence values represent the average ﬂuorescence over 20 data
points. To remove any effect of the dithionite/Tris solution, the percentage of
ﬂip-ﬂop in the absence of peptide at the same time measured for F in the
presence of peptide was subtracted from the percentage of ﬂip-ﬂop in the
presence of peptide. The assays were performed in triplicate.
NMR experiments
NMR samples for each peptide were prepared by dissolving ;3–5 mg of
peptide in 9:1 H2O:D2O; DSS was added as an internal chemical shift refer-
ence. One-dimensional (1D) 1H spectra were ﬁrst acquired for the peptide in
aqueous solution. The peptides were then solubilized in DPC-d38 at;1:100
of peptide/DPC to ensure one peptide molecule per detergent micelle. No
change in linewidth was observed when the ratio of peptide to detergent was
varied, suggesting that there is no contribution of peptide oligomerization.
More detailed studies of peptide oligomerization upon binding to membrane
mimetics would require studies with ﬂuorescence resonance energy transfer.
All NMR spectra were acquired on either a Bruker Avance 500 MHz
NMR spectrometer equipped with a Cryo-Probe or a Bruker Avance 700
MHz Ultrashield NMR spectrometer (Bio-NMR Centre, University of
Calgary, Calgary, Alberta, Canada). All spectra were referenced to 2,2-
dimethyl-2-silapentane-5-sulfonic acid (DSS). The mixing time for all
nuclear Overhauser enhancement and exchange spectroscopy (NOESY) spec-
tra was 100 ms and 60 ms for all total correlation spectroscopy (TOCSY)
spectra. Water suppression was performed using an excitation sculpting
pulse sequence for all TOCSY and NOESY spectra (30) and a Watergate
3-9-19 pulse sequence (31) for the correlation spectroscopy (COSY) spectra.
Spectra were processed using NMRPipe (32) on a PC workstation running
Redhat Linux 7.3. All spectra were zero-ﬁlled and multiplied by a shifted
sine-bell curve before Fourier transformation of the free induction decay
(FID). To determine if there were any slowly exchanging amide protons, a
deuterium amide exchange experiment was performed by dissolving a
lyophilized NMR sample in 99.9% D2O and immediately obtaining one-
dimensional 1H NMR spectra at different time intervals.
Structure calculation
Chemical shift assignment and nuclear Overhauser enhancement (NOE)
peak list generation were performed using the NMRView 4.1.3 software
package (33) on a PC workstation running the Redhat 7.3 version of the
Linux operating system. The assignment of the chemical shifts was deter-
mined using the method of Wu¨thrich (34). Where possible, stereospeciﬁc
assignments were made for well-resolved proton signals, such as the trypto-
phan and proline rings. All structure calculations were performed using
ARIA 1.1.2 (35–38). ARIA enables the incorporation of ambiguous NOE
distance restraints into the structure calculations, as well as calibrating the
NOE distance restraints using a structure-based NOE back calculation. For
non-Pro residues, a broad dihedral angle restraint was used in the structure
calculations to restrain the f-dihedral angle between35 and175. Each
ARIA run was performed with nine iterations, using the default parameters
supplied in the program. Peak lists that were compatible with ARIA were
generated by NMRView. In the ﬁnal ARIA run, the number of structures
generated in the ﬁnal iteration was increased to 100 while 20 structures were
retained based on lowest energy.
RESULTS
Antimicrobial assays
A standard microdilution method (25) was used to determine
both the minimal inhibitory concentration (MIC) and the
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minimal bactericidal concentration (MBC) for tritrpticin and
eight analogs of tritrpticin (Table 2). Due to the similarity in
amino acid composition between indolicidin and tritrpticin
and the thorough studies of this peptide reported in the liter-
ature, indolicidin was included as a reference peptide. In this
study, the antimicrobial activities of tritrpticin and indolici-
din were found to be very similar, as has been previously
observed (11). All of the peptides appear to be approximately
twofold more active against the Gram positive S. aureus bac-
teria compared to the Gram negative E. coli, agreeing with
previous reports for both tritrpticin and indolicidin (4,5,8,39).
The removal of the negative charge on the C-terminus by
amidation increases the net positive charge of a peptide,
which is generally observed to increase the antimicrobial
activity of antimicrobial peptides. The amidated tritrpticin
peptide, Tritrp1, has an approximately twofold greater acti-
vity than the parent tritrpticin peptide (Table 2). As all of the
remaining tritrpticin analogs used in this study also have an
amidated C-terminus, the activity of all of the peptides are
subsequently compared to Tritrp1. In general, there are very
few signiﬁcant differences in the antimicrobial activity of any
of these peptides, with Tritrp2, 3, 5, 6, and 7 all having similar
MIC andMBC values against E. coli compared to Tritrp1 and
tritrpticin. The only peptide in this study that had a signiﬁcant
loss in activity against both E. coli and S. aureuswas Tritrp4,
which had 5- to 10-fold less activity against E. coli and 2.5- to
5-fold less activity against S. aureus. The results observed for
Tritrp6 and 8 are also interesting; whereas the MIC values do
not appear to be very different fromTritrp1 for eitherE. coli or
S. aureus, the MBC values against E. coli increase ;2- to
2.5-fold in relation to Tritrp1 and the MBC values against
S. aureus remain similar, suggesting that the variations of the
Trp to Phe or the second Pro to Ala may increase the
selectivity for killing Gram positive bacteria.
Because the major requirement for an antibiotic is for it to
be selective for microbes versus human cells, the efﬁcacy of
an antimicrobial peptide must be determined by comparing
the antimicrobial and hemolytic activities (HA) for a given
peptide (Table 2). This can best be visualized by calculating
the therapeutic index for a peptide (Table 3), the ratio of its
hemolytic activity to either its MIC or MBC (HA/MIC or
HA/MBC). The selective nature of antimicrobial peptides
has long been attributed to the differences in the membrane
compositions of the outer leaﬂets of mammalian cells (these
commonly have neutral zwitterionic phospholipids head-
groups) and microbial cells (that normally have a net nega-
tive charge on their surface) (40). Therefore, it would be
expected that increasing the net positive charge of a peptide
by amidating the C-terminus should not only increase the
antimicrobial activity by removing the repulsion with the
phosphodiester groups, but also improve the selectivity of
the peptide for microbial cells. As mentioned above, the in-
crease in the net positive charge by amidating the C-terminus
slightly increases the antimicrobial activity of tritrpticin, but
there is also a corresponding increase in the hemolytic
activity (Table 2). This suggests that the presence or absence
of the negative charge may not improve the antimicrobial
selectivity of tritrpticin. There are four peptides in this study
that do not appear to cause any signiﬁcant hemolysis of red
blood cells, Tritrp2, 4, 6, and 7 (Table 2). Of these peptides,
the Trp to Tyr replacement in Tritrp4 results in a general loss
of activity (Tables 2 and 3). On the other hand, the replace-
ment of the four Arg by Lys (Tritrp2), the replacement of the
three central Trps by Phe (Tritrp6), or the single replacement
of the ﬁrst Pro at position 5 in tritrpticin by Ala (Tritrp7)
do not cause any signiﬁcant loss in antimicrobial activity,
exempliﬁed by their high therapeutic index (Table 3). The
related nonamidated versions of Tritrp2 and Tritrp6 demon-
strated similar decreases in hemolysis without any signiﬁcant
loss in antimicrobial activity (12,13). The substitution of
Pro-5 to Ala in Tritrp7 results in a major loss in hemolytic
activity compared to Tritrp1, but the substitution of Pro-9 to
Ala in Tritrp8 gives roughly half the hemolytic activity of
Tritrp1. The dual proline substitutions in Tritrp3 has an ap-
proximately threefold higher hemolytic activity than Tritrp1,
making it the peptide with the lowest therapeutic index value
in this study despite being highly antimicrobial.
TABLE 2 Antimicrobial and hemolytic activity of peptides
used in this study
MIC (mg/mL) MBC (mg/mL) Hemolysis
Peptide Variant E. coli S. aureus E. coli S. aureus EC50 (mg/mL)
Tritrpticin – 20 10–20 20 20 380
Tritrp1 NH2 10-20 ,2.5–5 10–20 10 190
Tritrp2 R/K 20 10 20 10 .1000
Tritrp3 P/A 10 5 10 10 60
Tritrp4 W/Y 50 20–25 100 25 .1000
Tritrp5 F/Y 20 5 20 10 220
Tritrp6 W/F 20 6 40 8 .1000
Tritrp7 P1/A1 20 4 20 7 .1000
Tritrp8 P2/A2 20 5 40 17.5 354
Indolicidin – 20 10 20 10 310
TABLE 3 Therapeutic index for the tritrpticin analogs
Therapeutic index
(Hemolysis/MIC) (Hemolysis/MBC)
Peptide Variant E. coli S. aureus E. coli S. aureus
Tritrpticin – 19 25 19 19
Tritrp1 NH2 13 51 13 19
Tritrp2 R/K 50 100 50 100
Tritrp3 P/A 6 12 6 6
Tritrp4 W/Y 20 44 10 40
Tritrp5 F/Y 11 44 11 22
Tritrp6 W/F 50 167 25 125
Tritrp7 P1/A1 50 250 50 143
Tritrp8 P2/A2 18 71 9 20
Indolicidin – 15 31 15 31
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Calcein leakage
Leakage of the contents of phospholipid liposomes by anti-
microbial peptides has often been assumed to be the result of
pore formation and is thought to be related to the lysis of
bacterial membranes (23,41). We have examined the leakage
proﬁles of the tritrpticin analogs in anionic vesicles, made
up of two phospholipid compositions, ePC:ePG (1:1) and
ePE:ePG (1:1) (Fig. 1). In the ePC:ePG LUVs (Fig. 1 A)
there is a clear distribution between those peptides that cause
high leakage (.60% at P/L of 1:10; tritrp1, 2, 3, 5, 7, 8, and
tritrpticin) and those that induce lower leakage (,40% at P/L
of 1:10; Tritrp4, 6, and indolicidin). With the exceptions of
Tritrp7 and the peptides that cause low overall leakage, the
maximum percentage leakage appears to be reached at a P/L
ratio of 1:20 in the ePC:ePG LUVs. It is interesting to note
that Tritrp7(P1/A1) has a different leakage dose-response
proﬁle compared to the other peptides that cause high leak-
age; instead of having a sigmoidal dose-response curve,
leakage appears to be much more linear in the range of P/L
ratios tested and may not yet have reached its maximal
leakage at the highest P/L ratio. This is similar to the pattern
of the peptides that induce low leakage, where the percentage
leakage is slowly increasing in a linear manner in the range
of P/L ratios assayed. The leakage proﬁles observed for
Tritrp2 also deviate from the majority of the peptides. Al-
though most of these peptides reach a maximal percentage
leakage 2 min after the addition of peptide, the kinetics for
the leakage induced by Tritrp2 appear to be quite a bit
slower, with the majority of leakage occurring only after
;5–10 min (Fig. 1 B). To verify the validity of the 10-min
assays, similar assays were also performed for as long as 7 h.
The results show that after 10 min, close to maximal leakage
has already occurred (data not shown).
In general, those peptides that induced high leakage in the
ePC:ePG LUVs (Fig. 1 A) also induced high leakage in the
ePE:ePG LUVs (Fig. 1 C). In the case of the ‘‘high leakers’’,
the percent leakage at a P/L ratio of 1:10 is generally as high
as was observed in the ePC:ePG LUVs or in the case of
FIGURE 1 Induction of calcein leak-
age from LUVs for the Tritrp analogs.
Summary of leakage experiments done in
triplicate from (A) 1:1 ePC:ePG, (C) 1:1
ePE:ePG LUVs, and (E) 2.5:1 ePC:cho-
lesterol. Sample calcein leakage proﬁles
in (B) ePC:ePG, (D) ePE:ePG, and (F)
ePC:cholesterol for Tritrp1 (trace 1) and
Tritrp2 (trace 2). The leakage proﬁle of
Tritrp1 is representative of all of the pep-
tides, except for Tritrp2, that cause signif-
icant leakage. The initial leakage event
occurs signiﬁcantly faster for Tritrp1 than
for the Tritrp2 peptide in all of the vesicle
systems studied here. All sample traces
were taken for a peptide to lipid ratio of
1:10.
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Tritrp1 and 3 the percent leakage surpasses the percent leak-
age observed in the ePC:ePG LUVs, nearing 100%. It should
be noted that in the concentration range tested it is not certain
if the maximal leakage occurred for any of the peptides in
ePE:ePG LUVs. The peptides that induced low leakage in
the ePC:ePG LUVs (Tritrp4, 6, and indolicidin) induced
even lower leakage in the ePE:ePG LUVs; this was espe-
cially apparent for Tritrp4 and 6, the two analogs in which
the three Trp residues have been replaced by either Tyr or
Phe. As in the ePC:ePG LUVs, Tritrp7 is also an exception in
the ePE containing LUVs. For this peptide, signiﬁcant leak-
age occurs at much higher P/L ratios than the other ‘‘high
leakers’’, but at a P/L of 1:10, the ﬁnal percent leakage is
much higher than the ‘‘low leakers’’, coming very close to
the ‘‘high leakers’’. The slow leakage kinetics mentioned
above for Tritrp2 also occurs in the ePE:ePG LUVs, al-
though the difference between Tritrp2 and the other peptides
is not as acute due to the slower leakage kinetics observed for
the other ‘‘high leakers’’ (Fig. 1 D).
In addition to determining the percent leakage from an-
ionic LUVs, calcein leakage from neutral vesicles composed
of egg-yolk phosphatidylcholine and cholesterol (ePC:cho-
lesterol 2.5:1) were also assayed (Fig. 1 E). It is interesting
that all of the tritrpticin analogs that had induced low hemo-
lysis (Tritrp2, 4, 6 and 7) also give rise to very low leakage
from the neutral LUVs at high P/L ratios (i.e., 1:10). This
was not unexpected for Tritrp4 and 6, which did not cause
signiﬁcant leakage in either of the anionic LUVs at these
concentrations. However, Tritrp2 and Tritrp7 both caused
signiﬁcant leakage from both ePC:ePG and ePE:ePG LUVs
at P/L ratios of 1:10. The most hemolytic peptide, Tritrp3,
also induced the most leakage from the ePC:cholesterol
LUVs. The remaining peptides (tritrpticin, indolicidin, and
Tritrp1, 5, and 8) induced both intermediate leakage and
intermediate hemolysis.
Lipid ﬂip-ﬂop
One of the mechanisms proposed to explain the membrane-
perturbing action of antimicrobial peptides is the formation
of ‘‘toroidal pores’’, comprised of peptides and lipids, on the
negatively charged bacterial membranes (41,42). To deter-
mine whether tritrpticin and its related analogs are capable of
forming toroidal pores, the degree of phospholipid ﬂip-ﬂop
was measured using vesicles asymmetrically labeled with an
NBD-labeled phosphatidylcholine lipid. A P/L ratio of 1:50
was used in these experiments since maximum leakage had
not yet been reached at this ratio in the calcein leakage
experiments with the ePC:ePG LUVs and it was expected
that differences in ﬂip-ﬂop would be more pronounced at this
ratio. It is assumed that the maximum ﬂip-ﬂop should be
;50% since after complete mixing of the two leaﬂets there is
an equal probability of ﬁnding an NBD-PC lipid in the inner
or outer leaﬂet, although this assumes that vesicle integrity is
retained during the reaction. All of the analogs studied here
induced lipid ﬂip-ﬂop to some degree in a time-dependent
fashion at a P/L of 1:50 (Fig. 2 A). The triplicates of these
assays resulted in the same relative percent ﬂip-ﬂop values
between the peptides. The peptides can be grouped in rela-
tion to the degree to which they induced lipid ﬂip-ﬂop. Those
peptides that induced low ﬂip-ﬂop (,10% ﬂip-ﬂop) included
Tritrp2, 4, 6, and indolicidin. Those peptides that induced
medium ﬂip-ﬂop (,20% ﬂip-ﬂop) included Tritrp7 and
tritrpticin while those that induced the highest ﬂip-ﬂop
(.20% ﬂip-ﬂop) included Tritrp1, 3, 5, and 8. The capacity
to induce lipid ﬂip-ﬂop correlates with the degree to which
the peptides caused calcein leakage from ePC:ePG LUVs at
the same P/L (Fig. 2 B), suggesting that lipid ﬂip-ﬂop is part
of the mechanism that gives rise to peptide-induced contents
leakage in phospholipid vesicles. It should be noted that
while the data for Tritrp2 and Tritrp7 would suggest that they
do not cause signiﬁcant lipid ﬂip-ﬂop, this could be the result
of the P/L used, since at higher ratios, such as 1:10, these
analogs caused higher levels of calcein leakage in ePC:ePG
LUVs, equal to that observed with the other, more active
peptides (Fig. 1 A).
FIGURE 2 Phospholipid ﬂip-ﬂop induced by the Tritrp analogs. (A) Per-
cent lipid ﬂip-ﬂop from ePC:ePG:NBD-PC 1:1:0.005 LUVs. (B) Correlation
between calcein leakage and lipid ﬂip-ﬂop from ePC:ePG LUVs at a peptide
to lipid ratio of 1:50, taken after 10 min.
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NMR spectroscopy and structure determination
DPC micelles were chosen as a membrane mimetic for NMR
studies due to their structural similarity to phospholipids,
including the presence of an interfacial phosphodiester group
and a choline headgroup. Previous experiments with tritrpticin
(43), have demonstrated that the tryptophan ﬂuorescence of
peptides in DPC micelles is similar to the tryptophan ﬂuo-
rescence observed in phospholipid vesicles. Additionally,
the ﬂuorescence and CD spectra of both indolicidin and its
analog, CP10A, in DPC micelles was very similar to that
observed in POPC LUVs (7). A further motivation for using
DPC rather than SDS in these studies is that there was
signiﬁcant chemical shift overlap for the original tritrpticin
peptide in SDS micelles (10), which was signiﬁcantly
reduced in DPC micelles. Initial studies with the Tritrp1 and
Tritrp3 analogs demonstrated much better resolved spectra at
37C than at 25C, therefore the NMR spectra for the
remaining peptides were acquired at 37C.
As previously observed for the parent tritrpticin peptide
(10), the free peptides in aqueous solution contained multiple
structural conformers. This is most likely due to cis-trans
proline isomerization, a common phenomenon in linear un-
structured peptides. This is most clearly evident by exam-
ining the tryptophan indole He1 region of the 1D 1H NMR
spectra (Fig. 3). In the 1D NMR spectra, the analogs that
retained the three central Trp residues and the two ﬂanking
Pro residues (Tritrp1, 2, and 5) had ;9–12 peaks present in
the Trp He1 region when dissolved in water alone. These
likely represent the four conformers that would be present
due to proline isomerization, likely in decreasing concentra-
tions related to their energetic stability (trans-trans . trans-
cis, cis-trans cis-cis). The presence of only nine signals is
probably due to cis-cis being in very low abundance and/or
signal overlap. Upon insertion of the peptides into DPC
micelles, the multiple conformers collapse into a single major
conformer (;95%), representing the energetically more fa-
vorable trans-trans conformation (see below). The conﬁr-
mation that this structural heterogeneity was most likely due
to cis-trans proline isomerization can be obtained when
examining the 1D-1H spectra of the three proline to alanine
analogs (Tritrp3, 7, and 8). Tritrp3 has only a single con-
former (only 3 Trp He1 signals) in both aqueous solution and
when inserted in DPC micelles. Simultaneously, Tritrp7 and
8, the single Pro to Ala analogs, have one major conformer,
FIGURE 3 One-dimensional proton spectra of the
He1-tryptophan region for different tritrpticin analogs in
aqueous solution and DPC micelles. All of the trypto-
phan containing analogs used in this study have three
Trp residues, therefore if a single structure is present,
only three signals should be observed. It should be noted
that for Tritrp3, the large signal inDPCmicelles is due to
two overlapping signals (as determined by 2D NMR
spectra).
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which is intensiﬁed upon insertion into DPC micelles, and a
single minor conformer due to the lone Pro residue. An in-
teresting observation is that in the minor conformer for
Tritrp7 in DPC micelles, one of the Trp residues has two He1
signals, possibly due to two stable backbone conformations
of this residue or two different rotameric states of its indole
side chain. The remaining two peptides, Tritrp4 and Tritrp6,
do not contain Trp residues, and therefore do not contain dis-
tinctive signals that can be used to observe multiple confor-
mations. However, upon comparing the ﬁngerprint amide-a
crosspeak region in the HSQC spectra of these two peptides
in DPC micelles to that of Tritrp1, it is clear that although a
major conformer is present, it is not in as high a concen-
tration as compared to the Trp-containing peptides (Fig. 4).
The lower concentration of a major conformer and the pres-
ence of at least two other minor conformers in the two-
dimensional (2D) spectra of Tritrp4 and 6 in the presence of
DPC micelles severely complicates the NMR assignment
and subsequent structure calculations. One of the backbone
amide protons from the Tritrp6 NOESY has a remark-
able chemical shift of 8.7 ppm, most likely due to ring
current effects in this highly aromatic peptide. It was there-
fore decided not to pursue NMR structures of these two
peptides.
While the peptides examined here are quite short (13 res-
idues), the line broadening due to the DPC detergent resulted
in signiﬁcant signal overlap for the ﬁve aromatic residues for
many of the peptides. Fortunately, the sequence similarity
between the six peptides helped us to resolve spectral overlap
issues. In general, the chemical shift assignments of the ﬁve
peptides were very similar and could be used to conﬁrm dif-
ﬁcult assignments in other peptides (Supplementary Mate-
rial). In particular, those residues that were packed near the
indole rings of the Trp residues had very distinctive chemical
shifts due to ring-current shifts, most notable were the HB2
and HG2 protons of Pro5, the indole HD1 ring proton of
Trp-7 and the amide proton of Trp-7 (Supplementary Mate-
rial). Where possible, stereospeciﬁc assignments were deter-
mined from distinctive NOE patterns for the side-chain
protons of the Pro residues. Additionally, all of the Pro resi-
dues were determined to be in the trans conformation based
on NOE patterns, speciﬁcally strong NOEs between the
proline d-protons and the a- and b-protons of the preceding
residue, as well as the absence of strong NOEs between the
proline a-proton and the preceding a- and b-protons.
A deuterium exchange experiment was performed for each
of the peptides to determine if any of the backbone amides
were involved in stable hydrogen bonds. The only peptide
that retained any amide signals immediately after becoming
solubilized in D2O was Tritrp3. The amide signals of Trp-8,
Phe-10, and Leu-11 remained for;30 min after the addition
of D2O. Due to chemical shift overlap with the aromatic pro-
tons, it was not possible to determine if the other C-terminal
amide protons (Trp-7, Ala-9, Arg-12, and Arg-13) also had
decreased exchange rates.
The Tritrp analog structures were determined using the
automated NMR assignment and structure calculation pro-
gram, ARIA (35–38). For each of the six structures deter-
mined, NOEs were determined from a NOESY spectrum
obtained at a NMR 1H frequency of 700 MHz. Additionally,
NOEs were also obtained from D2O NOESY spectra col-
lected at either 700 or 500 MHz. Where possible, NOEs were
assigned based on unambiguous chemical shift assignments
or on the most logical assignment from the previous ARIA
FIGURE 4 Two-dimensional TOCSY spectra of the Tritrp analogs that
have the three central tryptophan residues replaced by alternative aromatic
amino acids. (A) Tritrp1, (B) Tritrp4, and (C) Tritrp6 in DPC micelles,
demonstrating the structural inhomogeneity observed for tritrpticin analogs
that lack Trp residues. For each of these 13 residue peptides, a maximum of
10 amide-a resonances should be observed. In Tritrp1, there are ;10
resonances that correspond to the major conformer, and a few very weak
signals that are due to the presence of a minor conformer. However, there are
at least 30 signals present in the spectra for Tritrp4 and 6, implying a
minimum of three separate structures in solution. The multiple conformers
are most probably the result of cis-trans proline isomerization and are likely
more prevalent in Tritrp4 and 6 due to the absence of the membrane-
anchoring Trp residues. The peaks at ;4.65 ppm are the result of the NMR
signal from water. Spectra were acquired on a 500-MHz Avance Bruker
NMR spectrometer.
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run. Due to the chemical shift overlap present in the spectra
for all of the peptides, ambiguous NOEs were also incor-
porated and assigned by ARIA. Although, the deuterium
exchange results suggest that Trp-8, Phe-10, and Leu-11 of
Tritrp3 are present in hydrogen bonds, no hydrogen bond
restraints were incorporated in the structure calculations due
to their rapid exchange with deuterium. In the ﬁnal ARIA
run, 100 structures were calculated in the ninth iteration and
of these, the 20 structures with the lowest energy were
retained (Fig. 5). The statistics for the ﬁnal structures are
detailed in Tables 4 and 5.
The NMR solution structures of the six peptides for which
structures could be calculated can be classiﬁed into two dif-
ferent groups based on their backbone RMSD (Table 5) and
secondary structure (Fig. 6). The ﬁrst group has a turn-turn
structure, resembling the initial tritrpticin structure (10) and
includes Tritrp1, 2, 5, and 8. These four peptides retain the
proline at position 5 and are characterized by an extended
N-terminus, followed by two successive turns (Fig. 6). Pro-5
induces a b-turn made up of residues 5–8. This turn is likely
stabilized by a hydrogen bond between the carbonyl of Pro-5
and the amide proton of Trp-8, which is calculated to occur
in more than half of the structures determined for this class of
peptide. A speciﬁc restraint was not incorporated into the
structure calculations for this hydrogen bond and therefore it
does not occur in all of the structures. In structures where it is
not formed, it is due to a 180 rotation of the carbonyl of
Pro-5; although the remainder of the structures are not signif-
icantly altered by this rotation. The ﬁrst b-turn most closely
resembles a Type IV turn, based on the f and c angles of
Trp-6 and Trp-7 (using the structures that have a hydrogen
bond between residues 5 and 8). After this ﬁrst b-turn, there
is a short single turn of a-helix between residues 8 and 12 for
Tritrp1, 2, and 5. In the ﬁnal 20 structures of Tritrp8, this
second turn is not fully a-helical.
Aside from the turn-turn or turn-helix secondary structure,
these four structures are also characterized by a similar
clustering of their three tryptophan indole rings (Fig. 6). The
indole rings of Trp-6 and Trp-7 are perpendicular to each
other and the indole ring of Trp-8 lies somewhat parallel to
the ring of Trp-7. These interactions, as well as the clustering
of the remaining two aromatic side chains (Phe or Tyr), and
FIGURE 5 The 20 lowest energy struc-
tures from the 100 structures calculated in
the ﬁnal iteration of ARIA for the Tritrp
analogs in DPC micelles. (A) Tritrp1, (B)
Tritrp2, (C) Tritrp3, (D) Tritrp5, (E)
Tritrp7, and (F) Tritrp8. All structures are
overlaid for all heavy atoms for residues
3–12; the RMSD values for the different
structures is presented in Table 5. The
backbone of all structures is shown in
black, while the side chains of the Trp
residues are displayed in dark green, the
Phe or Tyr residues in dark violet, the Pro
and/or Ala residues in yellow, the Leu
residue in dark orange, and the Lys or Arg
residues in blue.
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the aliphatic side chain of Leu-11, form a distinctive hydro-
phobic face (Fig. 6). Additionally, while the four cationic
residues (either arginine or lysine) are localized to the termini
of the peptide, the turn-turn structure brings the N- and
C-termini together, forming compact amphipathic structures
(Fig. 5). The structures can be conﬁrmed by the unique ring
current shifts mentioned above. In Tritrp1, 2, 5, and 8 the
downﬁeld shifted HB2 and HG2 protons of Pro-5 and the
amide proton of Trp-7 are sandwiched between the indole
rings of Trp-6 and Trp-7, while the corresponding HB1 and
HG1 protons of Pro-5, which are not signiﬁcantly shifted
from their expected values (33), are facing away from the
indole rings (Fig. 6).
Tritrp3 and Tritrp7 make up the second class, and are
characterized by more helical structures (Fig. 6). The replace-
ment of both prolines by alanine in Tritrp3 induces a well-
deﬁned helix to form for residues 4–11. Tritrp3 was the only
peptide studied for which the amide protons were not im-
mediately exchanged with deuterium after the addition of
D2O, supporting the presence of hydrogen bonds in the
helical structure. This is similar to what has been reported
for the related Pro to Ala analog of indolicidin, CP10A (7).
Tritrp7 also forms a helix-like structure from Phe-4 to
Leu-11, but the rigidity of Pro-9 and its lack of an amide
proton results in a disruption of the helical bonding pattern
required for a perfect helix. The largest disruption in the
helix occurs between Trp-7 and Ala-5, with an average c
angle of 55 for Ala-5, likely due to the lack of a hydrogen
bond donor at position i 1 4 from Ala-5. But even with this
alteration in the hydrogen bonding pattern, the N-terminus
TABLE 4 Structural statistics for the ﬁnal NMR structures
Tritrp1 Tritrp2 Tritrp3 Tritrp5 Tritrp7 Tritrp8
No. of distance restraints*
Unambiguous NOEs 514 436 410 494 458 432
Ambiguous NOEs 40 43 32 51 51 9
Total NOEs 554 479 442 545 509 441
Intraresidue NOEs 235 208 174 242 205 217
Sequential NOEs 147 118 122 131 143 131
Medium range NOEs 124 106 95 108 100 71
Long range NOEs 48 47 51 64 61 52
Broad dihedral restraints 10 10 12 10 11 11
RMS distances from ideal values
Bonds (A˚) 1.0 3 102 6
4.0 3 104
7.6 3 103 6
6.0 3 104
7.0 3 103 6
4.7 3 105
7.36 3 103 6
1.1 3 104
9.4 3 103 6
4.2 3 104
1.86 3 103 6
6.38 3 105
Angles () 0.94 6 3.2
3 102
0.91 6 7.9
3 102
0.69 6 4.3
3 103
0.62 6 1.6
3 102
0.79 6 3.3
3 102
0.43 6 1.37
3 102
Impropers () 0.75 6 6.8
3 102
0.70 6 8.8
3 102
0.58 6 1.3
3 102
0.53 6 1.4
3 102
0.53 6 3.7
3 102
0.33 6 1.18
3 102
Van der Waals (kcal/mol) 81.5 6 4.2 70.5 6 6.1 67.0 6 1.9 52 6 1.0 85 6 6.4 20.6 6 1.2
Distance restraints
Unambiguous (A˚) 0.24 6 1.7
3 102
0.38 6 2.5
3 102
0.14 6 3.9
3 102
0.30 6 1.0
3 103
0.25 6 4.8
3 102
1.25 3 102 6
7.12 3 104
Ambiguous (A˚) 0 8.0 3 103 6
1.0 3 102
0.21 6 3.0
3 103
8.2 3 103 6
1.3 3 102
0.15 6 7.1
3 102
0
All distance restraints (A˚) 0.23 6 1.6
3 102
0.36 6 2.5
3 102
0.15 6 3.3
3 102
0.29 6 1.0
3 102
0.24 6 4.5
3 102
1.23 3 102 6
7.05 3 104
Dihedral restraints () 0 1.49 6 0.37 2.27 6 6.2
3 102
0 0.35 6 0.19 1.09 3 102 6
2.00 3 102
Nonbonded energies
Total Energy 183 6 48 300 6 85 235 6 99 263 6 66 243 6 58 199 6 16
Electronic (kcal/mol) 243 6 61 342 6 86 225 6 96 249 6 64 267 6 63 160 6 17
Van der Waals (kcal/mol) 111 6 26 104 6 24 104 6 42.7 118 6 27 118 6 27 117 6 0.93
Global RMSDs
Backbone (A˚) 0.963 1.00 0.465 0.986 0.313 0.579
Heavy atom (A˚) 1.730 1.593 1.337 1.951 1.220 1.233
Ramachandrany (%)
Most favored 60 54 79 67 39 46
Additionally allowed 16 23 8 25 46 26
Generously allowed 23 23 13 8 15 28
Disallowed 1 0 0 0 0 0
*Final data from the ﬁnal ARIA iteration.
yAs determined by Procheck.
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of the structure still resembles the helix observed for Tritrp3.
The helical nature of these two peptides results in a more
extended structure, with increased separation between the
N- and C-termini from what is observed in the turn-turn class
of peptides, altering the amphipathic nature of the peptides
(Fig. 5). Instead of all four cationic residues clustered to-
gether on the ‘‘top’’ of the structure, the positive charges are
localized to the ends of the peptides. Even with the seg-
regation of the basic residues, the amphipathic nature of the
peptide is retained, where the short alanine side chain(s)
result in a signiﬁcantly less hydrophobic surface than the
opposing face that includes the aromatic and Leu side chains.
The side chain of alanine can be considered intermediate
in hydrophobicity, although this is dependent on the hy-
drophobicity scale used (16,17). It may be energetically
favorable to have this side chain facing the solvent if these
peptides are inserted in the interfacial region of a phospho-
lipid bilayer.
One signiﬁcant difference between Tritrp3 and Tritrp7
appears to be in the clustering of the aromatic rings. The
tryptophan side chains of Tritrp7 are clustered in a similar
fashion as those in the turn-turn structures, with the indole
rings of Trp-6 and Trp-7 perpendicular to each other and
with the indole ring of Trp-8 stacked on top of the ring of
Trp-7. The phenylalanine and tryptophan side chains of
Tritrp3 are less compact than those in the turn-turn structures
and Tritrp7. The orientations of the aromatic side chains of
Tritrp3 more closely resemble those we have previously
observed for the helical NMR structure of the 19-residue
tryptophan-rich region of gp41 DPC micelles (44), which
forms a collar of aromatic resides on either side of the helix
backbone. It is noteworthy that the chemical shift of the
amide proton of Trp-7 is not signiﬁcantly upﬁeld shifted
in Tritrp3 (d ¼ 7.31), but in Tritrp7 the Trp-7 amide chemi-
cal shift (d ¼ 6.66) is in between that found in Tritrp3 and
the turn-turn peptides (average d ¼ 5.97), likely due to
possible hydrogen bonding of the amide of Trp-7 in the
helical structures and the reduced packing of the indole side
chains.
DISCUSSION
Most studies concerning a structure-function analysis of
antimicrobial peptides reported to date compare the structure
of a native peptide with an analog that has improved function
((7,45) for examples). In this work our objective was to make
comparisons across a larger group of closely related peptides
with different activities. Three classes of structures were
observed for this group of eight tritrpticin analogs when
bound to DPC micelles. For those analogs that do not have
any alterations in the central Trp residues or the ﬁrst Pro
residue, an amphipathic turn-turn structure is formed, similar
to the original NMR solution structure we reported for
tritrpticin in SDS micelles (10). The structures appear to be
determined more by intramolecular side chain–side chain
interactions and interactions with the DPC detergent (hydro-
phobic and electrostatic), than by intramolecular hydrogen
TABLE 5 Intramolecular backbone and heavy atom RMSD
values and the intermolecular backbone RMSD values for
residues 3–12 of the calculated peptide structures
Backbone RMSD for residues 3–12 (A˚)
1 2 3 5 7 8
1 0.279
2 0.689 0.325
3 1.103 1.241 0.192
5 0.708 0.509 1.277 0.274
7 1.336 1.474 0.786 1.479 0.185
8 1.210 1.004 1.483 0.958 1.434 0.184
Heavy atom RMSD for residues 3–12 (A˚)
0.894 0.787 0.936 1.005 0.846 0.835
FIGURE 6 Representative ribbon structures of the Tritrp analogs in DPC
micelles. (A) Tritrp1, (B) Tritrp2, (C) Tritrp3, (D) Tritrp5, (E) Tritrp7, and
(F) Tritrp8. The side chains of the Trp residues are displayed in dark green,
the Phe or Tyr residues in dark violet, the Pro or Ala residues in yellow, and
the Leu residue in dark orange. The side chains of the basic residues, as well
as the terminal valine side chain have been removed for clarity. All struc-
tures are in approximately the same orientation, with the C-terminus on the
left and the N-terminus on the right.
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bonds. However, some weak hydrogen bonds are likely pres-
ent, forming the C-terminal helical turn and stabilizing the
turn around residues 5–8. This still leaves a large proportion
of nonbonded hydrogen bonded donors and acceptors, for
which an energetic penalty must be paid after insertion into
either micelles or phospholipid bilayers. This penalty is likely
compensated by the abundance of aromatic and hydrophobic
residues in the central portion of the peptide (43).
The second structural class includes the peptides that
adopt more linear helical structures due to the replacement of
the ﬁrst Pro residue in the sequence. The replacement of Pro5
in both Tritrp3 and 7 allows the C-terminal helix to extend
the full length of the peptide. The helical class of structures
retains the amphipathicity observed for the turn-turn struc-
tures, although the helical nature causes the cationic residues
to be extended, with the short aliphatic alanine side chains
ﬁlling in the gap. The formation of a helix for the Pro to Ala
analog of tritrpticin in micelles has previously been sug-
gested on the basis of CD spectroscopy data (12). As the
majority of the aromatic residues and the hydrophobic leucine
side chain are on the opposing face from the alanine residues,
it is more likely that the alanines would be positioned away
from the hydrophobic core of a micelle or phospholipid
bilayer. The NMR structure of a Pro/Ala derivative of
indolicidin, also indicates an a-helical amphipathic struc-
ture (7).
The third structural class observed in these studies includes
Tritrp4 and 6, in which the central Trp residues were replaced
by either Tyr or Phe residues. While all of the peptides in this
study adopt multiple conformations in aqueous solution on
the NMR timescale (with the exception of Tritrp3, which has
no Pro residues), Tritrp4 and 6 retain their multiple confor-
mations even in the presence of detergent micelles. This is
probably related to their lower afﬁnity for the micelles com-
pared to the Trp-containing peptides. This is consistent with
thermodynamic predictions for whole amino acid residues
made by Wimley and White (17) of less favorable parti-
tioning between these two Trp-substituted peptides and the
membrane interface.
In this study, there are many hints as to possible mech-
anisms why some peptides may retain antimicrobial activity
yet not induce hemolysis, but in most cases there are also
exceptions to any proposed mechanisms. Therefore the attri-
bution of hemolysis to Trp as has been suggested (12) may
be an oversimpliﬁcation of the relationship between trypto-
phan and the hemolytic mechanism. While there is a reason-
able correlation between antimicrobial activity, membrane
bilayer perturbations, and the structures of the many peptides
in this study, the data for Tritrp6, the analog in which the Trp
are replaced with Phe, clearly does not ﬁt with the model of
the phospholipid bilayer being the primary target for its
antimicrobial activity. Tritrp6 is one of the most active pep-
tides used in this study (Table 2) with no detectable hemo-
lytic activity, yet it appears to have a very low membrane
perturbing activity as demonstrated in both the calcein
leakage assays (Fig. 1) and the lipid ﬂip-ﬂop assay (Fig. 2).
Buforin 2, a 21-residue cationic antimicrobial peptide that
does not kill bacteria by membrane disruption (46), has a
similar pattern of antimicrobial activity and low membrane
disruption characteristics as Tritrp6 (47). Although buforin 2
causes little membrane perturbation, it does translocate across
phospholipid bilayers (38), and it has an alternative intracel-
lular mode of action (47). Such mechanisms have also been
inferred for short Trp- and Arg-rich antimicrobial hexapep-
tides and heptapeptides (19–21). Additionally, Arg/Pro-rich
antimicrobial peptides, such as PR-39, will also translocate
bacterial membranes without leading to cell lysis, but instead
target intracellular macromolecular processes (1,48,49). Tritrp6
likely acts in a similar manner as these peptides.
There is a strong relationship between the hemolytic acti-
vities of these peptides (Table 2) and the degree to which
they cause leakage from ePC:cholesterol LUVs (Fig. 1 E).
The latter membrane mimetic system seems to be a good
indicator of lysis in red blood cells. Most of the peptides that
had low hemolytic activity also had low ﬂip-ﬂop activity.
The weaker hemolytic behavior of Tritrp4 and 6 may be
related to their weaker binding to phospholipid bilayers. The
relatively low hemolytic character of Tritrp2 compared to the
parent compound Tritrp1 must be explained by examining
differences between the interactions of the cationic side
chains of Arg and Lys with the different phospholipids found
in the membranes of bacterial and mammalian cells. For
example, in contrast to the amino group, the guanidino group
causes the positive charge to be spread out over three nitro-
gen groups and it also has extensive potential for making
several hydrogen bonds. Therefore, while at long range both
residues are cationic and contribute to electrostatic effects,
at short range these differences cause their side chains to
interact with PC and PE headgroups in a different manner.
Furthermore, cation-p interactions are possible between the
guanidino groups of the Arg side chains and the indole
p-electrons of the Trp side chains (1). These stable interactions
are thought to shield the positive charge of Arg, thereby
making it more favorable for the peptide to cross the hydro-
phobic core of bacterial membranes. This difference could be
observed in the different kinetics measured in the calcein
leakage experiments in Fig. 1, where only Tritrp2 showed
slow kinetics. It is interesting that in PE and PE/PG lipid
systems, there is often very little difference observed in the
effects of different charged residues in transmembrane pep-
tides on the phase behavior of phospholipids (50); yet in
PC containing lipid systems, differences have been observed
in the phase transition behavior induced by Arg and Lys
residues (51). Such effects may explain why Tritrp1 causes
signiﬁcant hemolysis in red blood cells and substantial leak-
age from ePC:cholesterol LUVs whereas Tritrp2 does not.
The structural similarities between Tritrp3 and Tritrp7,
with Pro-5 substituted, would suggest that these two helical
peptides could have similar interactions with phospholipid
bilayers. However, signiﬁcant differences were observed in
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their hemolytic activities (Table 2) and membrane interac-
tions (Figs. 1 and 2). Different Pro/Ala and Pro/Gly
analogs of indolicidin and other antimicrobial peptides have
been observed to not signiﬁcantly alter their antimicrobial
activity and yet make the peptides more hemolytic (8,52).
The aromatic residues of Tritrp3 form a collar around the
helical axis of the peptide, in a similar manner to the Trp-rich
membrane-proximal peptide of HIV gp41 (44). This gp41
peptide is extremely hemolytic and can cause signiﬁcant
leakage from phospholipid vesicles even at low peptide/lipid
ratios ((53); unpublished data). It is possible that the speciﬁc
positioning of the aromatic residues in a membrane interface
by a helical structure is key to membrane disruption of red
blood cells.
If all short (,25 residues) cationic antimicrobial peptides
are compared to each other in an attempt to correlate mem-
brane perturbation effects with antimicrobial activity there
does not appear to be a deﬁnitive link (6,7,21,54). However,
as this study has demonstrated, highly related peptides can
often have very different biophysical properties, which can-
not be directly correlated to their biological activities. There-
fore, a single unifying theory for large groups of peptides,
especially for those that have large differences in both se-
quence and structure, may not be applicable. This study and
others that have not observed a direct correlation between
membrane perturbation properties and MIC values (6,55)
deﬁnitely lends support to the notion that there are additional
targets for bactericidal activity. These targets could include
the outer components of the bacteria, composed mainly of
lipopolysaccharide on Gram negative bacteria and lipo-
teichoic acid on Gram positive bacteria (55), or intracellular
components (56). In such cases, the antimicrobial activity
would be determined by the sum of all of the effects of the
peptide on the outer membrane and the cytoplasmic mem-
brane and by binding to intracellular targets. By making
changes in the peptide sequence, the ratio between these dis-
tinct bactericidal activities could alter, yet the overall anti-
microbial effect could still be the same. Be that as it may, we
can not exclude at this stage that the assays that are used may
be oversimpliﬁed: i.e., LUVs that only contain one or two
lipids differ signiﬁcantly from the complex membrane envi-
ronment of bacteria. Therefore the complicated relationships
between amino acid composition, sequence, three dimen-
sional structure, membrane interactions, antimicrobial activ-
ity, and hemolytic activity may not be easily explained by
simple rules where one speciﬁc amino acid or one unique
secondary structure is always responsible for a speciﬁc
characteristic.
The atomic coordinates for the tritrpticin analogs (codes 2I1D (Tritrp1);
2I1E (Tritrp2); 2I1F (Tritrp3); 2I1G (Tritrp5); 2I1H (Tritrp7); and 2I1I
(Tritrp8)) have been deposited in the Protein Data Bank, Research Collab-
oratory for Structural Bioinformatics, Rutgers State University, New
Brunswick, NJ.
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